P4ML, a UAE-headquartered precision health and MultiOMICS intelligence company, has announced a strategic collaboration with global fitness technology innovator Speediance at CES 2026. Through a newly signed Memorandum of Understanding (MoU), the two companies plan to explore the development of a new class of AI-driven training systems that utilize internal biological responses, rather than simple activity metrics, to guide physical training and recovery.
Moving Beyond Standard Activity Tracking
The partnership aims to shift the focus of home fitness from traditional tracking—such as counting steps, movements, or calories—to a model based on deep biological insights. By combining smart gym technology with P4ML’s “OMICAssist” platform, the companies intend to create training programs that adjust dynamically to the individual user.
The objective is to translate complex health data into simple, actionable guidance, enabling users to “train smarter, not just harder”. This approach envisions a system that does not merely monitor external activity but provides insights into how training affects the body internally over time, offering a more personalized and behavior-informed health management model.
Strategic Alignment and Local Impact
This collaboration builds on P4ML’s increasing momentum within the region, following a commitment announced in November 2025 to create 100 skilled jobs in the UAE. That announcement, made alongside the UAE Minister of Economy and Tourism, positions P4ML’s growth in alignment with the UAE’s D33 economic agenda and national strategies for sports and wellbeing. P4ML was also recently recognized as a Future100 company at the world’s first Sport Summit hosted in Dubai.
Integrating MultiOMICS Intelligence
The core of this initiative lies in the integration of longitudinal MultiOMICS, biomarker, and performance data into the training experience. Unlike platforms that rely on generalized models or short-term metrics, the proposed AI training platform would learn from an individual’s specific biology to adjust resistance, volume, and progression.
Patrick Joseph Moloney, Founder and CEO of P4ML, stated:
“OMICAssist™ was created to close the gap between biological insight and real-world action. By exploring the embedding of MultiOMICS intelligence directly into the training experience, this collaboration aims to investigate its potential to redefine how fitness, recovery, and long-term health optimization is delivered; continuously, intelligently, and at global scale.”
Tao Liu, CEO of Speediance, emphasized that this partnership allows the company to enhance its intelligent coaching with biologically informed insights, where progress is measured by “true physiological adaptation and long-term resilience” rather than just strength or performance figures.
Governance and Future Pilots
The initial phase of the partnership will focus on technical integration, the design of pilot programs, and the establishment of governance frameworks. These frameworks will prioritize data privacy in accordance with regional regulations, ensuring informed consent and the ethical use of biological data. The companies noted that any future pilots, including potential activities in the UAE, will be subject to definitive agreements, with specific details on timelines and eligibility to be released at a later date.
About P4ML
P4ML is a precision health and MultiOMICS intelligence company headquartered in the UAE with roots in Ireland. As a Future100 company, it serves as a technology and implementation partner in precision medicine, combining data governance, trusted research environments, and mass spectrometry-based multi-omics. Through its OMICAssist™ platform, the company integrates longitudinal biological data and advanced analytics to enable actionable insights across clinical care and human performance.
Source: Press Release
